Cargando…
Comment on: "Preterm Physiologically Based Pharmacokinetic Model, Part I and Part II”
Autores principales: | Völler, Swantje, Flint, Robert B., Simons, Sinno H. P., Knibbe, Catherijne A. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113170/ https://www.ncbi.nlm.nih.gov/pubmed/33713305 http://dx.doi.org/10.1007/s40262-021-00993-4 |
Ejemplares similares
-
Pre- and Postnatal Maturation are Important for Fentanyl Exposure in Preterm and Term Newborns: A Pooled Population Pharmacokinetic Study
por: Wu, Yunjiao, et al.
Publicado: (2021) -
Maturation of Paracetamol Elimination Routes in Preterm Neonates Born Below 32 Weeks of Gestation
por: Wu, Yunjiao, et al.
Publicado: (2023) -
Enantiomer specific pharmacokinetics of ibuprofen in preterm neonates with patent ductus arteriosus
por: Engbers, Aline G.J., et al.
Publicado: (2020) -
Recently Registered Midazolam Doses for Preterm Neonates Do Not Lead to Equal Exposure: A Population Pharmacokinetic Model
por: Völler, Swantje, et al.
Publicado: (2019) -
Precision Dosing of Doxapram in Preterm Infants Using Continuous Pharmacodynamic Data and Model-Based Pharmacokinetics: An Illustrative Case Series
por: Poppe, Jarinda A., et al.
Publicado: (2020)